Skip to main content
Fig. 4 | Journal of Inflammation

Fig. 4

From: Downregulation of lncRNA-PVT1 participates in the development of progressive chronic kidney disease among patients with congestive heart failure

Fig. 4

Plasma PVT1 levels increased in CHF + CKD group during the follow-up. Plasma PVT1 levels in CHF + CKD group were measured prior to the treatment, and at 1, 2, and 3 months after the beginning of the treatment. Heatmaps were plotted using Heml 1.0 software to reflect the changes in plasma PVT1 levels

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us